Propranolol how supplied
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-525-6884
How supplied
Propranolol hydrochloride extended-release capsules, USP are available as follows:
60 mg
80 mg
120 mg
160 mg
Dispensing
Storage
60 mg
Each #3 capsule with white opaque cap and yellow opaque body printed with and 2778 on the cap and body in black ink contains 60 mg of Propranolol hydrochloride, USP.
Capsules are supplied in bottles of 100 (NDC 0228-2778-11) with a child-resistant closure and 500 (NDC 0228-2778-50) without a child-resistant closure. Return to top
80 mg
Each #3 capsule with yellow opaque cap and yellow opaque body printed with and 2779 on the cap and body in black ink contains 80 mg of Propranolol hydrochloride, USP.
Capsules are supplied in bottles of 100 (NDC 0228-2779-11) with a child-resistant closure and 500 (NDC 0228-2779-50) without a child-resistant closure.
Return to top
120 mg
Each #2 capsule with gray opaque cap and yellow opaque body printed with and 2780 on the cap and body in black ink contains 120 mg of Propranolol hydrochloride, USP.
Capsules are supplied in bottles of 100 (NDC 0228-2780-11) with a child-resistant closure and 500 (NDC 0228-2780-50) without a child-resistant closure.
Return to top
160 mg
Each #1 capsule with gray opaque cap and gray opaque body printed with and 2781 on the cap and body in black ink contains 160 mg of Propranolol hydrochloride, USP.
Capsules are supplied in bottles of 100 (NDC 0228-2781-11) with a child-resistant closure and 500 (NDC 0228-2781-50) without a child-resistant closure.
Return to top
Dispensing
Dispense in a tight, light-resistant container as defined in the USP. Return to top
Storage
Store at 20° to 25°C (68° to 77°F). Protect from light, moisture, freezing, and excessive heat. Return to top
The content of this page is taken from the FDA package insert for this drug and should not be edited.
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
